Faye A. Rogers

563 total citations
19 papers, 446 citations indexed

About

Faye A. Rogers is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Faye A. Rogers has authored 19 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Genetics. Recurrent topics in Faye A. Rogers's work include RNA Interference and Gene Delivery (10 papers), DNA and Nucleic Acid Chemistry (8 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Faye A. Rogers is often cited by papers focused on RNA Interference and Gene Delivery (10 papers), DNA and Nucleic Acid Chemistry (8 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Faye A. Rogers collaborates with scholars based in United States, Denmark and United Kingdom. Faye A. Rogers's co-authors include Peter M. Glazer, Karen M. Vásquez, Michael D. Miller, Diane S. Krause, Sharon Lin, Melissa P. Knauert, Denise C. Hegan, Julie L. Eiseman, Patrick S. Callery and Dorothy L. Sentz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Biotechnology.

In The Last Decade

Faye A. Rogers

18 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Faye A. Rogers United States	12	409	62	33	17	16	19	446
Masatoshi Wakamori Japan	10	361 0.9×	35 0.6×	30 0.9×	11 0.6×	12 0.8×	19	395
S. M. Gryaznov United States	6	502 1.2×	31 0.5×	19 0.6×	11 0.6×	15 0.9×	7	567
Edita Kriukienė Lithuania	13	428 1.0×	64 1.0×	6 0.2×	17 1.0×	19 1.2×	22	456
Naoya Ohmori Japan	13	350 0.9×	123 2.0×	15 0.5×	3 0.2×	16 1.0×	29	504
Felix Gnerlich Germany	8	367 0.9×	63 1.0×	9 0.3×	11 0.6×	12 0.8×	12	408
Michelle Gonzales-Cope United States	9	517 1.3×	47 0.8×	35 1.1×	6 0.4×	6 0.4×	9	554
Steven Lang United States	9	377 0.9×	101 1.6×	66 2.0×	6 0.4×	12 0.8×	11	436
Qiujia Chen United States	7	264 0.6×	36 0.6×	48 1.5×	3 0.2×	4 0.3×	13	313
Mark Pogson United States	10	240 0.6×	36 0.6×	45 1.4×	6 0.4×	16 1.0×	12	305
John J. Scarcelli United States	12	643 1.6×	52 0.8×	39 1.2×	3 0.2×	4 0.3×	17	686

Countries citing papers authored by Faye A. Rogers

Since Specialization

Citations

This map shows the geographic impact of Faye A. Rogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faye A. Rogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faye A. Rogers more than expected).

Fields of papers citing papers by Faye A. Rogers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faye A. Rogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faye A. Rogers. The network helps show where Faye A. Rogers may publish in the future.

Co-authorship network of co-authors of Faye A. Rogers

This figure shows the co-authorship network connecting the top 25 collaborators of Faye A. Rogers. A scholar is included among the top collaborators of Faye A. Rogers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faye A. Rogers. Faye A. Rogers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Liu, Yanfeng, et al.. (2025). PARP inhibitor resistance in IDH1-mutant cancers due to loss of end protection factors, 53BP1 and REV7. NAR Cancer. 7(4). zcaf047–zcaf047.

Quijano, Elias, Zaira Ianniello, Rashed Abdullah, et al.. (2024). Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition. Oncotarget. 15(1). 699–713. 2 indexed citations

Liu, Yanfeng, et al.. (2021). Vulnerability of IDH1-Mutant Cancers to Histone Deacetylase Inhibition via Orthogonal Suppression of DNA Repair. Molecular Cancer Research. 19(12). 2057–2067. 10 indexed citations

Liu, Yanfeng, Elias Quijano, Eric Song, et al.. (2021). Direct targeting of amplified gene loci for proapoptotic anticancer therapy. Nature Biotechnology. 40(3). 325–334. 21 indexed citations

Park, Hyun Bong, et al.. (2020). A DNA Repair Inhibitor Isolated from an Ecuadorian Fungal Endophyte Exhibits Synthetic Lethality in PTEN-Deficient Glioblastoma. Journal of Natural Products. 83(6). 1899–1908. 4 indexed citations

Rogers, Faye A., et al.. (2016). Triplex structures induce DNA double strand breaks via replication fork collapse in NER deficient cells. Nucleic Acids Research. 44(16). 7742–7754. 31 indexed citations

Kaspar, Roger L., Robyn P. Hickerson, Emilio González-González, et al.. (2015). Imaging Functional Nucleic Acid Delivery to Skin. Methods in molecular biology. 1372. 1–24. 1 indexed citations

Rogers, Faye A., et al.. (2014). Improved bioactivity of G-rich triplex-forming oligonucleotides containing modified guanine bases. PubMed. 5(1). e27792–e27792. 7 indexed citations

Rogers, Faye A., et al.. (2013). XPD-dependent activation of apoptosis in response to triplex-induced DNA damage. Nucleic Acids Research. 41(19). 8979–8994. 20 indexed citations

10.

Rogers, Faye A., et al.. (2013). Triplex-induced DNA damage response.. PubMed. 86(4). 471–8. 11 indexed citations

11.

Rogers, Faye A., Rong‐Hua Hu, & Leonard M. Milstone. (2012). Local Delivery of Gene-Modifying Triplex-Forming Molecules to the Epidermis. Journal of Investigative Dermatology. 133(3). 685–691. 9 indexed citations

12.

Schleifman, Erica, Ranjit S. Bindra, Jean Leif, et al.. (2011). Targeted Disruption of the CCR5 Gene in Human Hematopoietic Stem Cells Stimulated by Peptide Nucleic Acids. Chemistry & Biology. 18(9). 1189–1198. 47 indexed citations

13.

Rogers, Faye A., Sharon Lin, Denise C. Hegan, Diane S. Krause, & Peter M. Glazer. (2011). Targeted Gene Modification of Hematopoietic Progenitor Cells in Mice Following Systemic Administration of a PNA-peptide Conjugate. Molecular Therapy. 20(1). 109–118. 40 indexed citations

14.

Kim, Ki‐Hyun, et al.. (2009). Targeted correction of a thalassemia-associated -globin mutation induced by pseudo-complementary peptide nucleic acids. Nucleic Acids Research. 37(11). 3635–3644. 39 indexed citations

15.

Knauert, Melissa P., et al.. (2005). Distance and Affinity Dependence of Triplex-Induced Recombination. Biochemistry. 44(10). 3856–3864. 27 indexed citations

16.

Rogers, Faye A.. (2004). Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides. Nucleic Acids Research. 32(22). 6595–6604. 40 indexed citations

17.

Rogers, Faye A., Karen M. Vásquez, Michael D. Miller, & Peter M. Glazer. (2002). Site-directed recombination via bifunctional PNA–DNA conjugates. Proceedings of the National Academy of Sciences. 99(26). 16695–16700. 99 indexed citations

18.

Eiseman, Julie L., Faye A. Rogers, Yanping Guo, et al.. (1998). Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer.. PubMed. 58(21). 4864–70. 25 indexed citations

19.

Li, Yanlong, Julie L. Eiseman, Dorothy L. Sentz, et al.. (1996). Synthesis and Antitumor Evaluation of a Highly Potent Cytotoxic DNA Cross-Linking Polyamine Analogue, 1,12-Diaziridinyl-4,9-diazadodecane. Journal of Medicinal Chemistry. 39(1). 339–341. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact